OIA
BNGO icon

OneDigital Investment Advisors’s Bionano Genomics BNGO Stock Holding History

OneDigital Investment Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-21
Closed -$17K – 762
2022
Q2 		$17K Sell
21
-1
-5% -$1.03K ﹤0.01% 702
2022
Q1 		$33K Buy
+22
New +$29.7K ﹤0.01% 742
2021
Q4 		– Sell
-17
Closed -$57K – 797
2021
Q3 		$57K Buy
+17
New +$59.5K ﹤0.01% 738

Other funds holding BNGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

OneDigital Investment Advisors's BNGO Position: Q3 2022 in Review

OneDigital Investment Advisors sold out of Bionano Genomics (BNGO) in Q3 2022, closing a stake of 21 shares — an estimated $17K sold.

OneDigital Investment Advisors first reported a position in BNGO in Q3 2021 and held it in 3 quarters. The position peaked at $57K in Q3 2021. 140 funds tracked by Wall St. Rank hold BNGO as of Q3 2022.

  • OneDigital Investment Advisors reported no remaining Bionano Genomics position as of Q3 2022 after selling out during the quarter.
  • OneDigital Investment Advisors sold 21 Bionano Genomics shares in Q3 2022, an estimated $17K.
  • OneDigital Investment Advisors first reported a position in Bionano Genomics in Q3 2021 and held it in 3 quarters.
  • OneDigital Investment Advisors's Bionano Genomics position peaked at $57K in Q3 2021.
  • 140 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2022.

Based on OneDigital Investment Advisors's 13F filing for Q3 2022, filed 8 Nov 2022.